ZHANG Rui, HAN Mingfeng, TENG Xiaobao, et al. Intervention Effects of Special Management on Defined Daily Dose System and Rationality Evaluation Index of Carbapenem Antibiotics. [J]. 20(5):636-640(2020)
ZHANG Rui, HAN Mingfeng, TENG Xiaobao, et al. Intervention Effects of Special Management on Defined Daily Dose System and Rationality Evaluation Index of Carbapenem Antibiotics. [J]. 20(5):636-640(2020) DOI: 10.14009/j.issn.1672-2124.2020.05.033.
Intervention Effects of Special Management on Defined Daily Dose System and Rationality Evaluation Index of Carbapenem Antibiotics
摘要
目的:考察专档管理后阜阳市第二人民医院(以下简称"我院")碳青霉烯类抗菌药物用药频度(defined daily dose system
OBJECTIVE: To investigate the change trend of defined daily dose system(DDDs) of arbapenem antibiotics after special management and rationality evaluation index after twice of interventions in Fuyang the Second People’s Hospital(hereinafter referred to as "our hospital")
so as to provide scientific management basis for the rational application of carbapenems antibiotics in our hospital. METHODS: The sales data of carbapenem antibiotics before(2016) and after special management(from 2017 to 2019) from the special medical management system and the hospital information system in our hospital were collected.Totally 80 medical records of carbapenem antibiotics were randomly selected from Aug.to Sept.in 2018 and Aug.to Sept.in 2019
respectively
which were divided into the first intervention group and the second intervention group. Compare the rationality of carbapenem antibiotics DDDs before and after special management
and the indications of drug use
combined use
procalcitonin detection
and pathogen microbial submission after 2 interventions. RESULTS: The consumption sum of carbapenem antibiotics in our hospital increased from 2 214 300 yuan in 2016 to 3 075 700 yuan in 2018
and then decreased significantly to 2 029 300 yuan in 2019.The proportion of consumption sum of carbapenem antibiotics to total consumption sum of antibiotics decreased significantly from 17. 14% in 2016 to 6. 23% in 2019.The proportion of cumulative DDDs of carbapenem antibiotics to cumulative DDDs of antibiotics increased slowly from 5. 39% in 2016 to 5. 80% in 2017
and then decreased significantly to 3. 38% in 2019.The proportion of patients with appropriate drug indications increased from 53. 75% in the first intervention group to 72. 50% in the second intervention group
and the proportion of patients with proper drug selection increased significantly from 68. 75% in the first intervention group to 85. 00% in the second intervention group
the proportion of patients with records of procalcitonin detection
pathogen microbial examination and special application grade antibiotics increased from 52. 50%
66. 25% and 66. 25% in the first intervention group to 73. 75%
88. 75% and 83. 75% in the second intervention group
the differences were statistically significant(P<0. 05).There was no statistically significant difference in the suitability of usage and dosage
solvent selection and solvent dose between the first and second intervention groups(P > 0. 05). CONCLUSIONS: The specialized management of carbapenem antibiotics has dynamic trend of decreasing DDDs
consumption sum and consumption amount.The rational evaluation indexes after the second intervention
especially the suitability of drug indications and drug selection
were significantly improved compared with those after the first intervention
but the grasp of drug indications still needs to be improved.In order to avoid the increase of drug resistance of gram-negative bacteria caused by improper indications and abuse of carbapenem antibiotics
it is still necessary to strengthen the management of indications for clinical application of carbapenem antibiotics.
Analysis of Use of New Anti-Tumor Drugs in the First Affiliated Hospital of University of Science and Technology of China from 2017 to 2020
Investigation and Analysis of Application of Tamoxifen and Toremifene in the Treatment of Breast Cancer in 15 Grade Ⅲ,Level A Hospitals in Shanghai from 2015 to 2019
Analysis of Application of Hospital Preparations in Sichuan Provincial People’s Hospital from 2017 to 2019
Analysis on the Application of Oral Lipid-Regulating Drugs in Chinese PLA General Hospital During 2016-2018
Analysis of Application of Glaucoma Treatment Drugs in 114 Grade Ⅲ Level A hospitals in China from 2015 to 2017
Related Author
SHEN Aizong
CHENG Xi
ZHAI Qing
YU Bo
DU Qiong
FAN Jiazuan
WANG Mengmeng
SHUAI Xiaocui
Related Institution
Dept.of Pharmacy,the First Affiliated Hospital of University of Science and Technology of China/Anhui Provincial Hospital
Dept.of Pharmacy, Tongren Hospital,Shanghai Jiao Tong University School of Medicine
Dept.of Oncology,Shanghai Medical College, Fudan University
Dept.of Pharmacy,Fudan University Shanghai Cancer Center
Dept. of Pharmacy,Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital,Personalized Drug Therapy Key Laboratory of Sichuan Province